secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alamar Biosciences, Inc. (ALMR)
CIK:        0002104204
Form:       8-K
Filed at:   2026-09-01T20:01:24+00:00
Accession:  0001193125-26-378360
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Alamar Biosciences appoints Robert Ragusa to board as Class I director
----------------------------------------------------------------------

- Robert Ragusa appointed to Alamar Biosciences board effective Sept 1, 2026.
- Will serve as Class I director with term expiring at 2027 annual meeting.
- Appointed to Audit, Compensation, and Nominating/Corporate Governance committees.
- Compensated under Non-Employee Director Compensation Policy; standard indemnification agreement.
- No related party transactions or arrangements with other persons in selection.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2104204/000119312526378360/0001193125-26-378360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2104204/000119312526378360/d262303d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-378360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer